GLAXOSMITHKLINE CONSUMER HEALTHCARE — Paracetamol Importer Profile
Pharmaceutical Importer · #5 buyer for Paracetamol · $3.7M import value · 79 shipments · AUSTRALIA · DGFT Verified
GLAXOSMITHKLINE CONSUMER HEALTHCARE is the #5 importer of Paracetamol from India with $3.7M in import value and 79 verified shipments. GLAXOSMITHKLINE CONSUMER HEALTHCARE holds a 1.1% market share in Paracetamol imports based in AUSTRALIA. The company sources from 2 verified suppliers across 5 formulations shipped to 1 country.
GLAXOSMITHKLINE CONSUMER HEALTHCARE — Paracetamol Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Paracetamol to GLAXOSMITHKLINE CONSUMER HEALTHCARE?
Verified from 79 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| OLIVE HEALTH CARE | $3.1M | 66 | 84.5% |
| OLIVE HEALTHCARE | $577.3K | 13 | 15.5% |
GLAXOSMITHKLINE CONSUMER HEALTHCARE sources Paracetamol from 2 verified Indian suppliers based on 79 customs records. The primary supplier is OLIVE HEALTH CARE accounting for 84.5% of imports.
How Does GLAXOSMITHKLINE CONSUMER HEALTHCARE Compare to Nearest Paracetamol Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | ADCOCK INGRAM LIMITED | SOUTH AFRICA | $3.6M | 180 | $20.0K |
| 7 | IPCA LABORATORIES UK LIMITED | UNITED KINGDOM | $3.5M | 69 | $50.0K |
| 5 | GLAXOSMITHKLINE CONSUMER HEALTHCARE ★ | AUSTRALIA | $3.4M | 68 | $50.0K |
| 10 | BELLS HEALTHCARE | UNITED KINGDOM | $3.4M | 80 | $42.1K |
| 11 | CICI SARL | MALI | $3.3M | 111 | $29.8K |
GLAXOSMITHKLINE CONSUMER HEALTHCARE ranks #5 among 2,197 Paracetamol importers from India. Average shipment value of $50.0K compared to the market average of $32.6K. The closest competitors by value are ADCOCK INGRAM LIMITED and IPCA LABORATORIES UK LIMITED.
Where Does GLAXOSMITHKLINE CONSUMER HEALTHCARE Import Paracetamol To?
Destination countries from 79 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $3.7M | 79 | 100.0% |
GLAXOSMITHKLINE CONSUMER HEALTHCARE imports Paracetamol to 1 country. The primary destination is AUSTRALIA receiving 100.0% of shipments worth $3.7M.
What Paracetamol Formulations Does GLAXOSMITHKLINE CONSUMER HEALTHCARE Import?
| Formulation | Value | Shipments |
|---|---|---|
| PANADOL LIQUID CAPS (PARACETAMOL 500MG. | $2.7M | 54 |
| PANADOL LIQUID CAPS PARACETAMOL 500MG. | $377.3K | 9 |
| PANADOL LIQUID CAPS PARACETAMOL 500MG SOFT CAPSULES Each soft gelatin capsulecontains Paracetamol Ph Eur 500mg Bat | $300.0K | 6 |
| PANADOL LIQUID CAPS PARACETAMOL 500MG.SOFT CAPSULES Each soft gelatin capsulecontains Paracetamol Ph. Eur. 500mg. Ex | $200.0K | 4 |
| PANADOL LIQUID CAPS (PARACETAMOL 500MG.SOFT CAPSULES) EACH SOFT GELATIN CAPSULECONTAINS PARACETAMOL PH. EUR. 500MG. EXNOS | $166.1K | 6 |
GLAXOSMITHKLINE CONSUMER HEALTHCARE imports 5 distinct Paracetamol formulations from India. The top formulation is PANADOL LIQUID CAPS (PARACETAMOL 500MG. with 54 shipments worth $2.7M.
Regulatory Requirements: Importing Paracetamol into Australia
What GLAXOSMITHKLINE CONSUMER HEALTHCARE and other importers must comply with to import Paracetamol from India
Regulatory Authority
Therapeutic Goods Administration (TGA)
Approval Process for Generic Paracetamol
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
GMP Requirements
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
Import Licence & Documentation
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Labeling & Packaging
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Paracetamol from India and How Much Does GLAXOSMITHKLINE CONSUMER HEALTHCARE Import?
India exported $71.5M worth of Paracetamol through 15,000 shipments from 870 suppliers to 170 countries, serving 2,197 buyers globally. GLAXOSMITHKLINE CONSUMER HEALTHCARE imports $3.7M of this total, accounting for 1.1% of India's Paracetamol exports with 79 shipments from AUSTRALIA. This is verified from 79 customs shipment records covering 5 distinct formulations.
What Is the Average Order Value for GLAXOSMITHKLINE CONSUMER HEALTHCARE's Paracetamol Imports?
GLAXOSMITHKLINE CONSUMER HEALTHCARE's average Paracetamol order value is $47.1K per consignment, based on 79 shipments totaling $3.7M. GLAXOSMITHKLINE CONSUMER HEALTHCARE is based in AUSTRALIA and ranks #5 among all Paracetamol importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Paracetamol to GLAXOSMITHKLINE CONSUMER HEALTHCARE?
GLAXOSMITHKLINE CONSUMER HEALTHCARE sources Paracetamol from 2 verified Indian suppliers: OLIVE HEALTH CARE ($3.1M, 84.5%), OLIVE HEALTHCARE ($577.3K, 15.5%). This is based on 79 customs records.
How Does GLAXOSMITHKLINE CONSUMER HEALTHCARE Compare to Other Paracetamol Importers?
GLAXOSMITHKLINE CONSUMER HEALTHCARE ranks #5 among 2,197 Paracetamol importers from India with a 1.1% market share. The top 3 importers are ADCOCK INGRAM LIMITED. ($20.2M), ALLOGA UK AP7 ($9.6M), CENTRAFARM SERVICES B.V.(I) ($7.5M). GLAXOSMITHKLINE CONSUMER HEALTHCARE processed 79 shipments from AUSTRALIA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paracetamol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paracetamol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: GLAXOSMITHKLINE CONSUMER HEALTHCARE matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as GLAXOSMITHKLINE CONSUMER HEALTHCARE's capped import value divided by total capped export value for Paracetamol across all Indian exporters.
- 5.Verified Records: This page is backed by 79 individual customs records matching GLAXOSMITHKLINE CONSUMER HEALTHCARE importing Paracetamol, covering 5 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 170+ countries, 2,197+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paracetamol Import Data for GLAXOSMITHKLINE CONSUMER HEALTHCARE
Access order-level details, pricing data, supplier connections, and competitive analysis for GLAXOSMITHKLINE CONSUMER HEALTHCARE's Paracetamol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
GLAXOSMITHKLINE CONSUMER HEALTHCARE
Company Profile
Multiple products · $0 total trade · Multiple categories
GLAXOSMITHKLINE CONSUMER HEALTHCARE × Paracetamol
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for GLAXOSMITHKLINE CONSUMER HEALTHCARE.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paracetamol. For current order-level data, contact TransData Nexus.